动脉瘤性蛛网膜下腔出血早期白细胞趋势与结局的关联
该研究分析167例动脉瘤性蛛网膜下腔出血患者入院前5天白细胞计数与3个月改良Rankin量表(mRS)及迟发性脑缺血(DCI)的关联。功能结局不良者峰值白细胞更高(17×10^9 cells/L vs 13.5×10^9 cells/L)。峰值白细胞联合改良Fisher量表预测DCI的曲线下面积为0.670(95%CI 0.586-0.755)。
要点
- 早期白细胞峰值升高与动脉瘤性SAH后3个月功能结局不良相关。
- 峰值白细胞联合改良Fisher量表可轻度提高预测DCI的准确性。
- 白细胞监测或可辅助临床与影像工具进行风险分层。
核心结论
- 动脉瘤性SAH早期白细胞计数可能对预测DCI和功能结局具有预后价值。
研究设计与样本
- 回顾性分析连续动脉瘤性SAH患者队列,最终纳入167例,收集入院前5天白细胞值、临床影像数据及出院后3个月mRS。
主要发现
- 功能结局不良患者峰值白细胞均值17×10^9 cells/L(SD 6.4),功能结局良好患者为13.5×10^9 cells/L(SD 4.7)。
- 峰值白细胞联合改良Fisher量表预测DCI的AUC为0.670(95%CI 0.586-0.755),略高于单一指标。
关键数值与推荐
- 功能结局良好定义为mRS 0-3。
- 采用二元逻辑回归模型分析白细胞计数与mRS及DCI的关联,并用ROC曲线评估预测准确性。
临床怎么用
- 白细胞计数监测可与其他临床和影像工具联合,用于对SAH患者进行高风险与低风险分层,以调整神经监测和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An increasing white blood cell (WBC) count in early course of aneurysmal subarachnoid hemorrhage (SAH) can indicate a systemic inflammatory state triggered by the initial insult. We sought to determine the significance of the early WBC trend as a potential predictor of outcomes. METHODS: We analyzed a cohort of consecutive patients with aneurysmal SAH. The WBC values in first 5 days of admission, plus relevant clinical and imaging data, and modified Rankin Scale (mRS) at 3 months after hospital discharge were retrieved and analyzed. Favorable outcome was defined as mRS 0-3. The association between WBC counts and outcomes including mRS and delayed cerebral ischemia (DCI) was determined using binary logistic regression models. We used receiver operating characteristic curve analysis to assess accuracy of WBC in predicting outcomes. RESULTS: We included 167 patients in final analysis. Mean age was 56.4 (standard deviation [SD] 14.8) years, and 65% (109) of patients were female. Peak WBC was greater in patients with poor functional outcome (mean 17 × 109 cells/L, SD 6.4 vs. 13.5 × 109 cells/L SD 4.7). Combining peak WBC with modified Fisher scale slightly increased accuracy in predicting DCI (area under the curve 0.670, 95% confidence interval 0.586-0.755) compared with each component alone. CONCLUSIONS: WBC count in the early course of SAH may have prognostic values in predicting DCI and functional outcome. WBC count monitoring may be used in conjunction with other clinical and radiographic tools to stratify patients with SAH into high- and low-risk groups to tailor neuromonitoring and treatment strategies.
引用
- Mahta A, Azher AI, Moody S, et al. Association of Early White Blood Cell Trend with Outcomes in Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2021. PMID: 33964501. doi:10.1016/j.wneu.2021.04.124
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。